MREO

Mereo Biopharma

0.3177

-0.0141-4.25%

Pre Market: 0.3315 +0.0138 +4.34%04:00 07/01 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.3204/0.3230

TODAY RANGE0.3204-0.3397

VOL1.43M

MARKET CAP53.42M

52 WEEK RANGE0.2000-3.050

AVG VOL (3M)3.43M

% TURNOVER0.90%

TURNOVER--

P/E (TTM)-1.5002

% RANGE5.98%

EPS(TTM)-0.2231

P/E(FORWARD)-8.3466

P/B1.569

BVPS0.2133

DIVIDEND--

P/S107.97

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP53.03M

SHARES OUTSTANDING159.62M

NEXT EARNINGS08/10-08/14

FREE FLOAT158.43M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·05/15 11:37
Cantor Fitzgerald Remains a Buy on Mereo Biopharma Group Plc (MREO)
TipRanks·05/14 14:49
Mereo BioPharma Shareholders Approve All AGM Resolutions
Dow Jones·05/13 09:24
Mereo BioPharma Group Price Target Maintained With a $1.00/Share by BTIG
TipRanks·05/12 17:10
Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP) and Mereo Biopharma Group Plc (MREO)
TipRanks·05/12 13:52
Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO), DocGo (DCGO) and Spyre Therapeutics (SYRE)
TipRanks·05/12 11:43
Mereo BioPharma reports Q1 EPS (1c), consensus 0c
Seeking Alpha·05/12 11:32
Mereo BioPharma Group GAAP EPS of -$0.01 misses by $0.01
PR Newswire·04/06 06:32
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
PR Newswire·03/31 22:37
MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
PR Newswire·03/28 14:03
MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
TipRanks·03/27 12:15
Mereo Biopharma Announces Upcoming Board Change, Ensuring Continuity
TipRanks·03/26 12:21
Analysts Conflicted on These Healthcare Names: Erasca (ERAS) and Mereo Biopharma Group Plc (MREO)
TipRanks·03/24 11:16
Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims
Seeking Alpha·03/23 16:48
Mereo downgraded at JP Morgan on setrusumab regulatory uncertainty
Dow Jones·03/23 12:50
Mereo BioPharma Group Cut to Neutral From Overweight by JP Morgan

Same Industry

Name/Symbol

Change%

Price

Thermo Fishr Sci

TMO

+1.75%

522.32

Waters

WAT

-1.25%

369.73

Danaher Corporation

DHR

+1.75%

196.19

Fulgent Genetics

FLGT

-0.72%

20.67

RMD

CHKP

Agilent Technologies Inc

+0.19%

132.83

Abiomed Inc

ABMD

0.00%

381.02

Ge Healthcare Technologies Inc

GEHC

-1.08%

65.05

Intuitive Surgical Inc

ISRG

+1.25%

404.70

Veeva Sys Inc

VEEV

+2.92%

189.60

RVTY

Edwards Lifesciences Corp

+1.18%

90.78

Inmode Ltd.

INMD

+0.75%

14.74

ATHN

Bruker Corp

BRKR

+2.21%

61.51

VAR

ITGR

Hologic Inc

HOLX

0.00%

76.01

Quidel

QDEL

+0.66%

18.30

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.